NPI: 1427130392 · WASHINGTON, IL 61571 · 207R00000X
| Year | Claims | Total Paid |
|---|---|---|
| 2021 | 19,274 | $668K |
| 2022 | 314 | $14K |
| 2023 | 5,777 | $193K |
| 2024 | 4,193 | $233K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | 12,478 | 10,906 | $575K | |
| 87426 | 3,779 | 3,290 | $131K | |
| 99203 | 2,088 | 1,859 | $97K | |
| 99212 | 1,758 | 1,555 | $54K | |
| 99214 | 558 | 501 | $41K | |
| 87880 | 2,489 | 2,300 | $38K | |
| 59430 | 216 | 190 | $32K | |
| 0500F | 271 | 271 | $28K | |
| 87428 | 334 | 292 | $21K | |
| 87804 | 613 | 535 | $18K | |
| 99202 | 417 | 377 | $13K | |
| 99204 | 102 | 90 | $8K | |
| 99211 | 252 | 221 | $5K | |
| 73610 | 204 | 197 | $5K | |
| 73630 | 240 | 235 | $5K | |
| 71046 | 220 | 203 | $3K | |
| 73130 | 176 | 173 | $3K | |
| 12001 | 45 | 39 | $3K | |
| 81002 | 1,145 | 1,018 | $3K | |
| 87807 | 295 | 196 | $3K | |
| 99393 | 40 | 31 | $3K | |
| 81025 | 517 | 423 | $3K | |
| G2012 | Brief check in by md/qhp | 169 | 157 | $2K |
| 73564 | 97 | 92 | $2K | |
| 90715 | 60 | 47 | $2K | |
| 73110 | 82 | 79 | $2K | |
| 69209 | 154 | 129 | $1K | |
| 99394 | 17 | 16 | $1K | |
| 87502 | 13 | 12 | $934.18 | |
| 96372 | 89 | 66 | $882.90 | |
| 73140 | 47 | 46 | $819.11 | |
| 87635 | 13 | 12 | $667.03 | |
| 73030 | 29 | 29 | $599.40 | |
| 73080 | 28 | 27 | $496.25 | |
| 99421 | 30 | 27 | $395.70 | |
| 94640 | 18 | 15 | $261.00 | |
| 73090 | 14 | 13 | $221.21 | |
| J1885 | Ketorolac tromethamine inj | 152 | 118 | $195.36 |
| 81003 | 92 | 83 | $192.77 | |
| 82962 | 72 | 66 | $140.89 | |
| 86308 | 19 | 17 | $91.20 | |
| J0696 | Ceftriaxone sodium injection | 54 | 40 | $63.11 |
| J1100 | Dexamethasone sodium phos | 54 | 36 | $59.05 |
| J7613 | Albuterol non-comp unit | 18 | 15 | $1.96 |